Mechanism
Progranulin / Glycoprotein 88 (PGRN/GP88)
Assets acting on this target.
- Class
- Recombinant humanized monoclonal antibody (anti-PGRN/GP88)
- Pathway
- Blocks PGRN/GP88, a growth factor overexpressed in NSCLC, breast, ovarian and other cancers that drives tumor cell proliferation and treatment resistance